Suchergebnisse - "Fajgenbaum, David C."

PubPharm (12)

1

Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes

enthalten in: Blood advances | 2023

von Pierson, S. | Lim, M. | Srkalovic, G. | +13

2

A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease

enthalten in: European journal of immunology | 2023

von Brandstadter, J. | De Martin, A. | Lϋtge, M. | +15

UpdateOf: bioRxiv. 2023 Feb 07;:. - PMID 36798373

3

Organ dysfunction, thrombotic events and malignancies in patients with idiopathic multicentric castleman disease : a population-level US health claims analysis

enthalten in: Leukemia | 2022

von Mukherjee, S. | Kanhai, K. | Kauffman, D. | +6

ErratumIn: Leukemia. 2023 Jan;37(1):253. - PMID 36526737

4

Transcriptome and unique cytokine microenvironment of Castleman disease

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2022

von Wing, A. | Xu, J. | Meng, W. | +12

5

Optimisation of anti-interleukin-6 therapy : Precision medicine through mathematical modelling

enthalten in: Frontiers in immunology | 2022

von Rossi, J. | Chiang, H. | Lu, Z. | +5

6

Castleman disease

enthalten in: Nature reviews. Disease primers | 2021

von Carbone, A. | Borok, M. | Damania, B. | +5

7

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2021

von Pierson, S. | Shenoy, S. | Oromendia, A. | +22

8

DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells

enthalten in: The Journal of experimental medicine | 2021

von Lim, J. | Duttke, S. | Baker, T. | +11

9

Increased mTOR activation in idiopathic multicentric Castleman disease

enthalten in: Blood | 2020

von Arenas, D. | Floess, K. | Kobrin, D. | +14

CommentIn: Blood. 2020 May 7;135(19):1614-1615. - PMID 32379877

10

Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease

enthalten in: JCI insight | 2020

von Pai, R. | Japp, A. | Gonzalez, M. | +12